Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
Open Access
- 12 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (9), 2688-2692
- https://doi.org/10.1038/s41375-021-01153-0
Abstract
No abstract availableFunding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA190261)
- Starr Foundation (I4-A442)
- Leukemia and Lymphoma Society (SCOR 7006-13)
This publication has 16 references indexed in Scilit:
- Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 PatientsClinical Cancer Research, 2018
- WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemiaHaematologica, 2017
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemiaNature Medicine, 2016
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2016
- Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for DifferentiationPLOS ONE, 2015
- DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid LeukemiaCell Reports, 2014
- Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid LeukemiaPLOS ONE, 2014
- The prevalent predicament of relapsed acute myeloid leukemia.Hematology, 2012
- Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapyLeukemia, 2002